
Veeva Systems (VEEV) Stock Forecast & Price Target
Veeva Systems (VEEV) Analyst Ratings
Bulls say
Veeva Systems is a highly innovative and financially stable company with a strong presence in the growing life sciences industry. With a goal of $6B in revenue by 2030 and expanding product portfolio, Veeva shows potential for continued growth despite some risks related to AI and clinical trial timelines. With a good value for its stock and a positive long-term outlook, Veeva Systems is a solid investment option.
Bears say
Veeva Systems is a leading provider of cloud-based solutions for the life sciences industry, but macro conditions for biopharma are mixed and may only be stabilizing through its core offerings for customer relationship management. While Veeva's projected growth for FY27 and 2030 targets appear achievable, there may be additional pressure from regulatory changes impacting pricing and R&D investment, as well as a looming patent cliff that could trigger a need for more M&A activity in the industry.
This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.
Veeva Systems (VEEV) Analyst Forecast & Price Prediction
Start investing in Veeva Systems (VEEV)
Order type
Buy in
Order amount
Est. shares
0 shares